Related Experiment Video
Updated: Jun 14, 2026
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Development and Validation of an ELISA Method for Quantification of HuB01 in Fermentation Products
Yuying Liu1, Yao Zhang1, Ling Li1
1Beijing Health Guard Biotechnology Inc., BDA, Beijing, China.
Background:
The antibodies (including 7C4, 8D1) are neutralizing antibodies specifically targeting the protein RBD, a key core of the combination with angiotensin-converting enzyme 2 (ACE2). In order to measure HuB01 in fermentation products accurately, a bioanalytical method was needed, which should have high selectivity and be free from interference by 501Y.V2.
Methods And Results:
To quantify HuB01 in fermentation products, an indirect ELISA was developed and validated, utilizing anti-idiotypic monoclonal antibodies for both capture and detection. The assay demonstrates high sensitivity, with a lower limit of quantification set at 3.906 ng/mL, a wide dynamic range spanning 3906-125 ng/mL for HuB01, and outstanding precision and accuracy.
Conclusion:
A sensitive and selective method for measuring HuB01 in fermentation products has been developed and validated by us. Currently, this assay is applied in the quality control of the production process.
